JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 6 570-573
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, G.
Right arrow Articles by Hakala, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, G.
Right arrow Articles by Hakala, T.

Localization of I-131-Labeled Tumor-Specific Monoclonal Antibody in the Tumor-Bearing BALB/c Mouse

Geoffrey Levine, Byron Ballou, Jean Reiland, Davor Solter, Lewis Gumerman and Thomas Hakala

University of Pittsburgh Schools of Medicine and Pharmacy, Veterans Administration Hospital, Pittsburgh, Pennsylvania
Wistar Institute, Philadelphia, Pennsylvania

Correspondence: For reprints contact: Geoffrey Levine, PhD, Presbyterian-Univ. Hospital, Dept. of Nuclear Medicine, Pittsburgh, PA 15213.

ABSTRACT

One of the most frequent indications for patient imaging is the need to establish the presence or absence of malignant disease. Considerable effort has been invested in attempting to develop tumor-specific radiopharmaceuticals. We report the localization of an iodine-131-labeled, hybridoma-derived monoclonal antibody in the MH-15 teratocarcinoma-bearing BALB/c mouse. Tumor-to-muscle and tumor-to-blood ratios of 150:1 and 15:1, respectively, were observed at 5 days after administration of 15 µCi of labeled antibody. The relationship between the optimal imaging time and localization kinetics is discussed.




This article has been cited by other articles:


Home page
ScienceHome page
J. Weinstein, M. Steller, A. Keenan, D. Covell, M. Key, S. Sieber, R. Oldham, K. Hwang, and R. Parker
Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor
Science, October 28, 1983; 222(4622): 423 - 426.
[Abstract] [PDF]


Home page
ScienceHome page
J. Weinstein, R. Parker, A. Keenan, S. Dower, H. Morse 3rd, and S. Sieber
Monoclonal anitbodies in the lymphatics: toward the diagnosis and therapy of tumor metastases
Science, December 24, 1982; 218(4579): 1334 - 1337.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.